GR3030873T3 - Serum-human albumin, preparation and utilization. - Google Patents

Serum-human albumin, preparation and utilization.

Info

Publication number
GR3030873T3
GR3030873T3 GR990401634T GR990401634T GR3030873T3 GR 3030873 T3 GR3030873 T3 GR 3030873T3 GR 990401634 T GR990401634 T GR 990401634T GR 990401634 T GR990401634 T GR 990401634T GR 3030873 T3 GR3030873 T3 GR 3030873T3
Authority
GR
Greece
Prior art keywords
pct
serum
preparation
human albumin
utilization
Prior art date
Application number
GR990401634T
Other languages
English (en)
Inventor
Jerome Becquart
Reinhard Fleer
Gerard Jung
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9425981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3030873(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of GR3030873T3 publication Critical patent/GR3030873T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
GR990401634T 1992-01-27 1999-07-29 Serum-human albumin, preparation and utilization. GR3030873T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9200807A FR2686620B1 (fr) 1992-01-27 1992-01-27 Serum-albumine humaine, preparation et utilisation.
PCT/FR1993/000072 WO1993015204A1 (fr) 1992-01-27 1993-01-26 Serum-albumine humaine, preparation et utilisation

Publications (1)

Publication Number Publication Date
GR3030873T3 true GR3030873T3 (en) 1999-11-30

Family

ID=9425981

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401634T GR3030873T3 (en) 1992-01-27 1999-07-29 Serum-human albumin, preparation and utilization.

Country Status (16)

Country Link
US (1) US5612196A (el)
EP (1) EP0625202B1 (el)
JP (1) JP3390990B2 (el)
AT (1) ATE182623T1 (el)
AU (1) AU686996B2 (el)
CA (1) CA2126356C (el)
DE (1) DE69325794T2 (el)
DK (1) DK0625202T3 (el)
ES (1) ES2137251T3 (el)
FI (1) FI943512A7 (el)
FR (1) FR2686620B1 (el)
GR (1) GR3030873T3 (el)
HU (1) HU218353B (el)
NO (1) NO310418B1 (el)
NZ (1) NZ249153A (el)
WO (1) WO1993015204A1 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CA2136564C (en) * 1993-11-26 2008-04-08 Kaoru Kobayashi Process for producing human serum albumin
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050244931A1 (en) * 2001-04-12 2005-11-03 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003030821A2 (en) * 2001-10-05 2003-04-17 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
CN102816241B (zh) * 2004-02-09 2015-07-22 人类基因科学公司 清蛋白融合蛋白
EP1831373A2 (en) * 2004-12-22 2007-09-12 Novozymes A/S Recombinant production of serum albumin
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
CN102127164B (zh) 2010-12-20 2013-01-30 武汉禾元生物科技有限公司 一种从水稻种子中提取重组人血清白蛋白的方法
CN102532254B (zh) 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
JP6247210B2 (ja) 2011-07-05 2017-12-13 アルブミディクス アクティーゼルスカブ アルブミン製剤及び用途
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
CN103880947B (zh) 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
PT3240798T (pt) * 2015-01-01 2020-05-07 Shilpa Medicare Ltd Novo método para purificação eficiente de albumina do soro humana
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
EP4558516B1 (en) 2022-07-18 2025-08-13 Yeda Research and Development Co. Ltd Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
NL7708005A (nl) * 1976-07-22 1978-01-24 Monsanto Co Werkwijze voor de bereiding van serumalbumine.
JPS62294621A (ja) * 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
FR2635115B1 (fr) * 1988-08-05 1992-04-03 Rhone Poulenc Sante Procede de preparation de la serum albumine humaine a partir d'une levure
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
GB8923521D0 (en) * 1989-10-18 1989-12-06 Delta Biotechnology Ltd Yeast promoter
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
FR2677996B1 (fr) * 1991-06-21 1993-08-27 Rhone Poulenc Rorer Sa Vecteurs de clonage et/ou d'expression preparation et utilisation.

Also Published As

Publication number Publication date
WO1993015204A1 (fr) 1993-08-05
EP0625202B1 (fr) 1999-07-28
DE69325794T2 (de) 2000-01-13
JP3390990B2 (ja) 2003-03-31
NO942780D0 (no) 1994-07-26
AU686996B2 (en) 1998-02-19
HU218353B (hu) 2000-08-28
FR2686620A1 (fr) 1993-07-30
ATE182623T1 (de) 1999-08-15
US5612196A (en) 1997-03-18
HU9401960D0 (en) 1994-09-28
NO942780L (no) 1994-07-26
EP0625202A1 (fr) 1994-11-23
NZ249153A (en) 1996-03-26
CA2126356A1 (fr) 1993-08-05
FI943512L (fi) 1994-07-26
FI943512A0 (fi) 1994-07-26
AU3503893A (en) 1993-09-01
DE69325794D1 (de) 1999-09-02
FR2686620B1 (fr) 1995-06-23
HUT70570A (en) 1995-10-30
JPH07503137A (ja) 1995-04-06
FI943512A7 (fi) 1994-07-26
ES2137251T3 (es) 1999-12-16
NO310418B1 (no) 2001-07-02
DK0625202T3 (da) 2000-02-28
CA2126356C (fr) 2003-03-18

Similar Documents

Publication Publication Date Title
HUT70570A (en) Serum-human albumin, preparation and utilization
AU655915B2 (en) Cosmetic deodorants
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
IL122174A0 (en) Novel CD40L mutein
CA2186747A1 (en) Interleukin-15
CZ63995A3 (en) Virus vectors and their use in gene therapy
BG100974A (en) Vaccines against papillomavirus
DE59506355D1 (de) Chromatographische isolierung von nucleinsäuren
GB2302329B (en) Yeast strains
AU3078892A (en) Human interleukin-8 analogs
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
GR3024667T3 (en) Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use.
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
AU2174392A (en) Adn sequences of the human papillomavirus type 42, and diagnostic application thereof
ATE161713T1 (de) Feuchtigkeitsspender
TW251283B (el)
EP0257063A4 (en) COMPOSITIONS CONTAINING 1-SUBSTITUTED AZACYCLOALKANES AND THEIR USE.
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
DE69425061D1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
ZA932748B (en) Water-soluble retinoids
Tipton et al. Letter to Readers, Table of Contents, and Members of the National Seminar on Jesuit Higher Education
GB9710636D0 (en) Novel mixture
Hampson Consumer culture and social relations: white middle class nostalgia.